Pulmonary Arterial Hypertension

Related by string. pulmonary arterial hypertension * PULMONARY . pulmonary : treat pulmonary arterial . cardio pulmonary resuscitation CPR / arterials : pulmonary arterial hypertension PAH / HYPERTENSION : persistent pulmonary hypertension * Pulmonary Arterial Hypertension PAH . Pulmonary arterial hypertension PAH . idiopathic pulmonary arterial hypertension *

Related by context. All words. (Click for frequent words.) 79 Meets Primary Endpoint 79 Prolongs Survival 78 Phase III Clinical Trial 77 Oral Fingolimod 77 Severe Sepsis 77 Clinical Trial Results 76 Overactive Bladder 76 Single Dose 76 Phase 2b Clinical Trial 76 Fondaparinux 76 Phase IIb Trial 76 Gout Drug 76 Investigational Drug 76 Allergic Rhinitis 76 JAK Inhibitor 76 ST Elevation Myocardial 76 Combination Treatment 76 Fungal Infections 76 Renal Cell Carcinoma 76 Study Evaluating 75 Novel Mechanism 75 Acute Ischemic Stroke 75 Oral Mucositis 75 Previously Treated 75 Phase 2b Study 75 Hepatocellular Carcinoma 75 Diabetic Nephropathy 75 Novel Antibiotic 75 Relapsing Multiple Sclerosis 75 Advanced Melanoma 75 Rheumatoid Arthritis Patients 75 Heart Failure Patients 75 Antitumor Activity 75 Clinical Trial Evaluating 75 Novel Oral 75 Well Tolerated 75 NDA Submission 75 Aliskiren 75 Drug Candidate 75 Study Showed 75 Elderly Patients 75 Investigational Treatment 75 Shows Efficacy 75 Chronic Hepatitis B 74 Lupus Drug 74 Improves Outcomes 74 Diabetic Neuropathy 74 Hypercholesterolemia 74 Epilepsy Drug 74 Improves Survival 74 Treatment Resistant 74 Phase 2a Trial 74 Diabetic Patients 74 Phase III Trial 74 Complicated Skin 74 Initiate Phase 74 Monotherapy 74 Phase 2b Trial 74 Successfully Completes Phase 74 Investigational Compound 74 Initiates Phase III 74 Preclinical Data 74 Phase IIb Clinical Trial 74 Glatiramer Acetate 74 Treatment Regimen 73 Immunosuppressant 73 Is Well Tolerated 73 Pooled Analysis 73 Advanced Renal Cell 73 See CLINICAL PHARMACOLOGY 73 Investigational Agent 73 Prospective Randomized 73 Metastatic Colorectal Cancer 73 Initiate Clinical Trial 73 Efficacy Trial 73 Kidney Transplant Patients 73 Minimally Invasive Treatment 73 Phase III Pivotal 73 First Patient Enrolled 73 Receives Orphan Drug Designation 73 Completes Patient Enrollment 73 Myelodysplastic Syndromes 73 Resistant Hypertension 73 Schizophrenia Treatment 73 Treated Patients 73 Gastric Cancer 73 Chronic Hepatitis C 73 Myeloma Patients 73 Adjuvant Therapy 73 Liver Failure 73 Benign Prostatic Hyperplasia 73 Patients Suffering 73 Chronic Sinusitis 73 Tiotropium 73 Osteoporosis Drug 73 Schizophrenia Drug 73 Pediatric Patients 73 Neoadjuvant Chemotherapy 73 Bipolar Depression 73 Initiates Clinical 73 Survival Benefit 73 Venous Thromboembolism 73 Therapeutic Potential 73 Adjuvant Chemotherapy 73 Treating Chronic 73 Patient Enrollment 73 Tyrosine Kinase Inhibitor 73 Hormone Refractory Prostate Cancer 73 Interferon Beta 73 Acute Heart Failure 73 Newly Diagnosed Multiple Myeloma 73 Phase III Trials 73 Oral Insulin 73 Combo Therapy 73 Inhaled Nitric Oxide 73 Acute Coronary Syndromes 73 Knee Osteoarthritis 73 Subgroup Analysis 72 Plaque Psoriasis 72 Improve Survival 72 Chronic Renal Failure 72 Cholesterol Lowering Drug 72 Phase III Clinical Trials 72 Postmenopausal Osteoporosis 72 Combination Therapy 72 Pivotal Phase III 72 Inflammatory Markers 72 Liver Injury 72 Dose Escalation 72 Controlled Trial 72 Pafuramidine 72 Hepatitis C Virus 72 Severe Asthma 72 Significantly Improved 72 Anticancer Agent 72 Metastatic Prostate Cancer 72 Improved Survival 72 Oral Calcitonin 72 Phase 2a Clinical Trial 72 Long Term Efficacy 72 Breast Cancer Recurrence 72 Adalimumab 72 Pivotal Study 72 Multiple Myeloma Patients 72 Metastatic Melanoma 72 Nicotine Vaccine 72 Patients Receiving 72 Renal Function 72 Valsartan 72 Advanced Colorectal Cancer 72 Patients Treated With 72 Etanercept 72 Autologous Stem Cell Transplantation 72 Solid Tumors 72 Septic Shock 72 Pivotal Phase 72 Demonstrates Positive 72 Ranolazine 72 Anemia Drug 72 Dupuytren Contracture 72 Renal Cancer 72 Initiates Enrollment 72 Inhaled Insulin 72 Lung Cancer Drug 72 Secondary Hyperparathyroidism 72 Oral Spray 72 Rotavirus Vaccine 72 Shows Promising 72 Chronic Myeloid Leukemia 72 Ischemic Stroke 72 Lupus Nephritis 72 Chronic Heart Failure 72 Insulin Resistance 72 Initiates Clinical Trial 72 Blood Pressure Drug 72 Inhaled Corticosteroids 72 Sapacitabine 72 RNAi Therapeutic 72 Arthritis Drug 72 Protease Inhibitor 72 Metabolic Disorder 72 ACE Inhibitors 72 Efficacious 72 Nebulized 72 Inflammatory Disease 72 Clinical Outcome 72 Antipsychotic 72 Drug Shows Promise 72 Patients Undergoing 72 Intravenous Formulation 72 Transdermal Patch 72 Proven Effective 72 Infected Patients 72 Pirfenidone 72 Antithrombin 71 Hormone Receptor Positive 71 IND Application 71 Asthma Treatment 71 Treatment Naïve 71 Dasatinib 71 Enlarged Prostate 71 Tesamorelin 71 Disease Progression 71 Demonstrates Efficacy 71 Files IND 71 Demonstrates Potent 71 II Clinical Trial 71 Beta Blocker 71 Hepatic Encephalopathy 71 Prostate Cancer Vaccine 71 Localized Prostate Cancer 71 FDA APPROVES 71 Controlled Study 71 RNAi Therapeutics 71 Bone Metastases 71 Advanced Prostate Cancer 71 Anti Tumor Activity 71 Fabry Disease 71 IND Filing 71 Mouse Model 71 Unfractionated Heparin 71 Appears Safe 71 Treatment Naive Patients 71 Osteoarthritis Patients 71 Statistically Significant 71 Myocardial Ischemia 71 Anti Tumor 71 Preclinical Study 71 Advanced Pancreatic Cancer 71 Reduces Mortality 71 Bosutinib 71 Diabetic Foot Ulcer 71 Atopic Dermatitis 71 Hospital Acquired Pneumonia 71 Randomized Double Blind 71 Natalizumab 71 dual endothelin receptor antagonist 71 Rilonacept 71 Tezampanel 71 Adjunctive Therapy 71 Skeletal Muscle 71 FDA Approvals 71 Maleate 71 Improve Outcomes 71 Antiplatelet 71 Versus Placebo 71 Glufosfamide 71 VIVITROL ® 71 Randomized Phase 71 Osteoarthritis Pain 71 Pivotal Trial 71 Phase IIa Clinical Trial 71 Inflammatory Arthritis 71 Fracture Risk 71 Relapsed Multiple Myeloma 71 Rheumatoid Arthritis Drug 71 Iron Overload 71 Placebo Controlled Trial 71 Estrogen Therapy 71 Hepatitis B Vaccine 71 Avian Flu Vaccine 71 Adjuvant Treatment 71 Granted Orphan Drug 71 Thyroid Hormone 71 Enzyme Replacement Therapy 71 Hepatotoxicity 71 Double Blind Placebo 71 Teva Provides Update 71 Taxane 71 Lung Cancer Patients 71 Degarelix 71 Atypical Antipsychotics 71 Increased Mortality 71 Patient Outcomes 71 Golimumab 71 Bipolar Mania 71 Novel Compound 71 Fewer Side Effects 71 Unstable Angina 71 Cardiovascular Outcomes 71 Demonstrates Significant 71 Fibromyalgia Pain 70 Milestone Payment 70 Endovascular Treatment 70 Renal Anemia 70 Artery Disease 70 Lung Injury 70 Predict Risk 70 Osteoporosis Treatment 70 Prophylactic Treatment 70 Hematological Malignancies 70 Microalbuminuria 70 Initiates Phase II 70 Maribavir 70 Prostate Cancer Patients 70 Malignant Melanoma 70 Disease Modifying 70 Low Dose 70 Diabetic Macular Edema 70 Myelofibrosis 70 Confirmatory Phase 70 Double Blind Randomized 70 Romiplostim 70 Psoriasis Drug 70 Partial Onset Seizures 70 Lung Cancer Survival 70 Premature Infants 70 Effectively Treats 70 Successfully Treated 70 Methylnaltrexone 70 Serious Infections 70 Sustained Release 70 rilonacept 70 Eculizumab 70 Tumor Growth 70 First Patient Dosed 70 Mycophenolate Mofetil 70 Oral Formulation 70 Treating Heart Failure 70 Nesiritide 70 Cholesterol Drug 70 Epratuzumab 70 Inhaled Liposomal Ciprofloxacin 70 Regenerative Cells 70 Treat Anemia 70 Testosterone Gel 70 Carotid Stenting 70 Ebola Vaccine 70 Critically Ill Patients 70 Hypertensive Patients 70 Peginterferon 70 Anticoagulant 70 Dendritic Cells 70 Symptom Relief 70 Completes Enrollment 70 Bevacizumab 70 Aflibercept 70 Potent Inhibitor 70 Relapsed Refractory 70 Relapsing Remitting Multiple Sclerosis 70 Sustained Reduction 70 Clinical Trial Data 70 HCV Protease Inhibitor 70 Stem Cell Treatment 70 Anti Inflammatory Drug 70 Significantly Improves 70 Novel Therapeutic 70 Statin Therapy 70 Safinamide 70 Decitabine 70 Brain Metastases 70 JAK2 Inhibitor 70 Metastatic Renal Cell Carcinoma 70 Present Preclinical Data 70 Melphalan 70 Treatment Experienced 70 Dual Antiplatelet Therapy 70 Community Acquired Pneumonia 70 Patients Treated 70 Randomized Double blind 70 SPRYCEL ® 70 Valvular Heart Disease 70 Hyperuricemia 70 Corticosteroid 70 Sevelamer 70 Anticancer Drug 70 Ambrisentan 70 Hepatitis C Infection 70 Interferon Gamma 70 Preclinical Models 70 TB Vaccine 70 Anti Clotting Drug 70 Seasonal Influenza Vaccine 70 Recombinant Human 70 Asthma COPD 70 Aurora Kinase 70 Recurrent Breast Cancer 70 Pemetrexed 70 Contrast Agents 70 Acute Decompensated Heart Failure 70 Hepatitis C Treatment 70 ARIXTRA R 70 Peginterferon Alfa 2a 70 Presents Preclinical Data 70 Urinary Incontinence 70 Enoxaparin 70 Myelodysplastic Syndrome MDS 70 Clinical Evaluation 70 Multicenter Trial 70 Autoimmune Disease 70 Anticancer Activity 70 Inflammatory Diseases 70 Denufosol 70 Fast Track Status 70 Allogeneic 70 Acute Myocardial Infarction 70 Nitazoxanide 70 Migraine Drug 70 Placebo Controlled Study 70 Inhalation Aerosol 70 Previously Untreated 70 Non Alcoholic Fatty 70 Hepatitis C Genotype 70 Pharmacokinetic Study 70 Tocilizumab 70 Demonstrate Significant 69 Presents Positive 69 Lung Cancer Trial 69 Antiviral Activity 69 Left Ventricular 69 NICE Recommends 69 Valve Replacement 69 Drug Fails 69 FOLOTYN ® 69 Pivotal Clinical Trial 69 Ischemic 69 Demonstrated Significant 69 Mylan Receives Approval 69 Autoimmune Diseases 69 Osteoporosis Drugs 69 Dyslipidemia 69 Blood Thinner 69 Nymox NX 69 Renal Impairment 69 FDA Okays 69 Kinase Inhibitor 69 Potent Antiviral Activity 69 Generic Version 69 Menopausal Symptoms 69 Statin Drugs 69 Zileuton 69 Progressive Multifocal Leukoencephalopathy 69 Inhalation Solution 69 Ventricular Arrhythmias 69 Combination REOLYSIN R 69 TNF Tumor Necrosis Factor 69 Randomized Study 69 Newly Diagnosed 69 Clinical Efficacy 69 Castration Resistant Prostate Cancer 69 C1 Inhibitor 69 Abciximab 69 Neoadjuvant 69 Achieves Primary Endpoint 69 Trandolapril 69 Tolvaptan 69 ORENCIA ® 69 Cocaine Addiction 69 Anti TNF 69 Antidepressant Drug 69 Migraine Headaches 69 Preterm Delivery 69 ZOLINZA 69 PROCRIT R 69 Immunotherapeutic 69 Invasive Fungal Infections 69 Shows Promise Against 69 Smallpox Vaccine 69 Cardiotoxicity 69 Therapeutic Antibody 69 Randomized Clinical Trial 69 Diabetic Kidney Disease 69 Diuretic 69 Fixed Dose 69 Proves Effective 69 HER2 Positive Breast Cancer 69 Slow Progression 69 Insulin Glargine 69 Seasonal Allergic Rhinitis 69 Montelukast 69 Portal Hypertension 69 Cardiovascular Events 69 Cutaneous T 69 Capsules CII 69 Hsp# Inhibitor 69 Epidermal Growth Factor Receptor 69 Positive Opinion 69 ADHD Medication 69 Critical Limb Ischemia 69 Unresectable 69 Uric Acid 69 Monoclonal Antibody 69 Naive Patients 69 Critical Limb Ischemia CLI 69 Vildagliptin 69 Confirms Efficacy 69 Nilotinib 69 Iron Deficiency 69 R lenalidomide 69 Cell Transplants 69 Chronic Lymphocytic Leukemia 69 Radiofrequency Ablation 69 Hemodialysis Patients 69 Atypical Hemolytic Uremic Syndrome 69 Platelet Inhibition 69 Peptic Ulcer 69 Acute Pain 69 Idiopathic Pulmonary Fibrosis 69 PKC# 69 Phase 1b Clinical Trial 69 Submits NDA 69 Replacement Therapy 69 Tigecycline 69 Novel Therapies 69 Randomized Phase II 69 Desvenlafaxine Succinate 69 Neovascular Age Related Macular 69 Pegylated Interferon 69 Treatment Reduces 69 Immune Mediated 69 Demonstrates Sustained 69 Randomized Evaluation 69 Dose Ranging Study 69 Prostate Cancer Treatment 69 Visceral Fat 69 Acute Renal Failure 69 Randomized Clinical Trials 69 Drug Resistant 69 Migraine Pain 69 HDAC Inhibitor 69 Soft Tissue Sarcoma 69 Begins Dosing 69 Boceprevir 69 Adjunctive 69 Atomoxetine 69 Expanded Indication 69 Generic Versions 69 Potentially Fatal 69 Antiepileptic Drug 69 Guidelines Issued 68 Stress Incontinence 68 Venous Thrombosis 68 Data Suggest 68 Drug Combo 68 Chronic Bronchitis 68 Left Ventricular Dysfunction 68 Budesonide 68 Erectile Dysfunction Drug 68 Urinary Tract Infections 68 Topical Treatment 68 Showed Significant 68 Adult Stem Cell Therapy 68 Anthracycline 68 Aortic Valve Replacement 68 Omalizumab 68 adalimumab Humira 68 PDUFA Date 68 Smooth Muscle 68 Hematopoietic Stem Cell Transplantation 68 Effective Treatments 68 Chemotherapy Induced 68 Immune Responses 68 Epoetin Alfa 68 Transdermal Delivery 68 Kidney Function 68 Orally Active 68 Virus Infection 68 Omacetaxine 68 Oral Cladribine 68 Acne Drug 68 Late Breaker 68 oral dual endothelin 68 Myelodysplastic Syndrome 68 Pulmonary Hypertension 68 Drug Prevents 68 Angiogenic 68 Ceflatonin R 68 Diabetic Neuropathic Pain 68 Tracleer R 68 PEGylated anti 68 Ozarelix 68 Randomized Phase III 68 Breast Cancer Treatment 68 Receptor Antagonists 68 Lymphocytic 68 Extended Release 68 Kinase Inhibitors 68 Biomarker Study 68 Telithromycin 68 Novel Inhibitor 68 Antiangiogenic 68 Bortezomib 68 Immunosuppression 68 First Patient Treated 68 Gene Variation 68 Advanced Ovarian Cancer 68 Phase Ib Clinical Trial 68 Patients Enrolled 68 Gemcitabine 68 Tumor Response 68 Obese Patients 68 Significantly Reduced 68 Aztreonam Lysine 68 Hematological Cancers 68 Diastolic Heart Failure 68 Dose Response 68 Acute Pancreatitis 68 Sustained Efficacy 68 Laryngeal Cancer 68 Pegloticase 68 Study Demonstrates 68 Receptor Agonist 68 Moxifloxacin 68 Respiratory Virus 68 Hemorrhagic Stroke 68 Prophylaxis 68 Cholesterol Drugs 68 Sleep Disturbances 68 Prognostic Significance 68 Heart Transplant Recipients 68 Efficacy Results 68 Colorectal Cancer Patients 68 Small Molecule 68 FDA Approves Drug 68 Interferon beta 1a 68 Treat Heart Failure 68 Malignant Glioma 68 Meta Analysis 68 Intravesical 68 Retinal Vein Occlusion 68 Candesartan 68 Decompensated Heart Failure 68 Kidney Failure 68 Metabolic Endocrinology 68 Gene Linked 68 Synthetic Peptide 68 ST Segment Elevation 68 Testosterone Patch 68 Gaucher Disease 68 Primary Hypercholesterolemia 68 Shingles Vaccine 68 Therapy Reduces 68 Prospective Multicenter 68 Mg Usa 68 Sinus Infections 68 Clinical Guideline 68 Trial Evaluating 68 GW# [003] 68 Antifungals 68 Allergic Asthma 68 Invasive Breast Cancer 68 Refractory Hodgkin Lymphoma 68 Initiates Dosing 68 Benign Prostatic Hyperplasia BPH 68 Chemotherapy Regimen 68 Premenopausal Women 68 Doripenem 68 Recurrent Ovarian Cancer 68 ACE Inhibitor 68 Bepreve TM 68 Bronchiectasis 68 Cardiovascular Disease Risk 68 Female Sexual Arousal 68 Personalized Immunotherapy 68 Vaprisol 68 Antipsychotic Drug 68 Rotavirus Vaccines 68 Proton Pump Inhibitor 68 Stent Thrombosis 68 Intravascular 68 Clostridium difficile Infection 68 Nuclear Receptors 68 Initiates Phase 2b 68 Lipid Lowering 68 Salmeterol 68 Complete Remission 68 Lubiprostone 68 BARACLUDE R 68 Progenitor Cells 68 INTEGRILIN R 68 Multicenter Randomized 68 Post Operative 68 Liver Damage 68 Palonosetron 68 Vitrasert R 68 Teriparatide 68 Randomized Double Blind Placebo 68 MEK Inhibitor 68 Immunomedics Announces 68 STELARA TM 68 Lymphoid 68 Antiviral Drugs 68 Excessive Sweating 68 Aggressive Prostate Cancer 68 Tumor Necrosis Factor 68 Betaferon R 68 Lamotrigine 68 Epilepsy Drugs 68 Contrast Agent 68 Fluticasone 68 Hospitalized Patients 68 Vicriviroc 68 NAVISTAR R 68 Blood Cancers 68 Significantly Reduces 68 Stomach Cancer 68 Cognitive Deficits 68 Abstract Accepted 68 Initiate Phase II 68 Aortic Stenosis 68 Tanespimycin 68 Neuroprotective Effects 68 Signaling Pathway 68 Bivalirudin 68 Polymerase Inhibitor 68 Levoleucovorin 68 Stent Placement 68 Itraconazole 68 Prolongs Life 68 Endometrial Cancer 68 Panic Disorder 68 Thrombotic 68 Gastrointestinal Stromal Tumors 68 Cysteamine 68 Breast Cancer Cells 68 Uterine Fibroid Embolization 68 PRIALT 68 Metastatic Cancer 68 Immune Cell 68 icatibant 68 Newly Diagnosed Patients 68 Eltrombopag 67 Metabolic Disease 67 Postmenopausal Women 67 Receptor Antagonist 67 Cognitive Impairment 67 Lung Function 67 Drug Coated Stents 67 Eszopiclone 67 Microplasmin 67 Receives Orphan Drug 67 Medication Errors 67 Malaria Vaccine 67 Interferon Alfa 67 Simulect 67 Receives Approvable Letter 67 HER2 Positive 67 Transplant Patients 67 Platinol ® 67 Bosentan 67 ACTEMRA TM 67 Rheumatoid 67 Non Responders 67 Liprotamase 67 Thrombus 67 methylnaltrexone bromide 67 Receives Positive Opinion 67 HCV Genotype 67 Less Invasive 67 Total Knee Arthroplasty 67 IN PATIENTS WITH 67 Suicidality 67 Proton Pump Inhibitors 67 Maven Semantic 67 Surgical Mesh 67 Serious Side Effects 67 Thromboembolism 67 Cancer Treatments 67 Ziprasidone 67 efalizumab 67 Intravitreal 67 Cinacalcet 67 FS Antihemophilic Factor Recombinant 67 Catheter Ablation 67 Pneumococcal Vaccine 67 Randomized Controlled Trials 67 Heterozygous Familial Hypercholesterolemia 67 Develop Novel 67 Anticoagulation 67 Bone Marrow Transplants 67 Parenteral Nutrition 67 Lowers Risk 67 Bucindolol 67 Therapy Evaluation 67 Rheumatoid Arthritis RA 67 Liver Metastases 67 Risk Stratification 67 Long Term Survival 67 Vaccine Candidate 67 Mitoxantrone 67 Therapeutic Antibodies 67 Beta Blockers 67 Chemoradiation 67 Node Positive 67 Mirapexin 67 Elagolix 67 Lenalidomide 67 beta 1a 67 Epoprostenol 67 Infarct 67 LibiGel ® 67 Peripheral Arterial 67 Carotid Endarterectomy 67 Zorbtive TM 67 Nonalcoholic Fatty Liver Disease 67 Refractory Angina 67 Gene Variant 67 Skin Lesions 67 Hyperlipidemia 67 Uterine Fibroids 67 Ovarian Cancer Patients 67 Coronary Arteries 67 vapreotide acetate 67 Reduces Risk 67 Cardiometabolic 67 Anti CD# Antibody 67 Hyperkalemia 67 Antisense Drug 67 Cyclophosphamide 67 Antiplatelet Therapy 67 Beneficial Effects 67 Chronic Constipation 67 Daclizumab 67 FASLODEX 67 Treatment Shows Promise 67 lucinactant 67 Pivotal Trials 67 Breast Cancer Metastasis 67 Bladder Cancer 67 Paroxysmal Atrial Fibrillation 67 Anticoagulants 67 MMR Vaccine 67 Antihypertensive 67 Sangamo BioSciences Announces 67 Bone Marrow Stem Cells 67 Initiates Clinical Trials 67 Adverse Event 67 ® pioglitazone HCl 67 Stakeholder Opinions 67 FDA Accepts 67 Heartburn Drugs 67 Generalized Anxiety Disorder 67 APTIVUS 67 Electrical Stimulation 67 Perindopril 67 Liver Cancer 67 Mg Uk 67 Analytical Tool 67 Shown Effective 67 Hormone Therapy 67 Androgen Deprivation Therapy 67 Topical Cream 67 Liver Cirrhosis 67 Therapeutic Efficacy 67 Antitumor 67 Experimental Vaccine 67 PEGylated Fab fragment 67 Lung Tumors 67 Sipuleucel T 67 Commence Phase 67 interferon gamma 1b 67 Levels Linked 67 SEROQUEL R 67 Muscle Function 67 Chronic Insomnia 67 Gene Mutation 67 Muscle Wasting 67 Telbivudine 67 FDA Approvable Letter 67 Pulmonary Arterial Hypertension PAH 67 Chronic Myelogenous Leukemia 67 Mitral Regurgitation 67 Deforolimus 67 Pazopanib 67 Gemzar ® 67 TRANSDUR ™ 67 Silodosin 67 Stem Cell Transplants 67 Tacrolimus 67 Higher Doses 67 ALN HPN 67 Intracerebral Hemorrhage 67 Abdominal Pain 67 Genetic Variant 67 Capecitabine 67 Protein Involved 67 VAPRISOL 67 Kidney Transplant Recipients 67 Parathyroid Hormone 67 Cethromycin 67 Orphan Status 67 Genetic Tests 67 Carboplatin Paclitaxel 67 PHASE III 67 Hepatitis C Patients 67 Medoxomil 67 Diabetic Ulcers 67 Glucocorticoid 67 Remission Maintenance 67 Attenuates 67 Azacitidine 67 Non Invasive Treatment 67 Differential Diagnosis 67 Slows Progression 67 Febuxostat 67 Commercialize Novel 67 Breast Cancer Stem Cells 67 Atypical Antipsychotic 67 Radiation Induced 67 Cimzia ® certolizumab pegol 67 Antifungal 67 Thiazolidinediones 67 Renal Tumors 67 Hematological 67 Bazedoxifene 67 Psoriasis Patients 67 Gene Variants 67 Initiate Phase III 67 non peptidic protease 67 Vimpat R 67 Posaconazole 67 Valproic Acid 67 Alemtuzumab 67 Topline Results 67 Juvenile Idiopathic Arthritis 67 Advanced Solid Tumors 67 LUMINATE 67 Fibromyalgia Syndrome 67 Cholesterol Lowering 67 Tyrosine Kinase Inhibitors 67 Zoledronic Acid 67 Dapagliflozin 67 Diagnostic Criteria 67 Bremelanotide 67 ritonavir boosted 67 Stent Restenosis 67 DIRECT Trial 67 Severe Chronic Pain 67 Emerging Therapies 67 Azathioprine 67 SNT MC# 67 R pioglitazone HCl 67 Plus Ribavirin 67 Preclinical Efficacy 66 TNF Blockers 66 Rotigotine 66 Reduced Risk 66 Corneal Transplant 66 Multiple Ascending Dose 66 Novel Treatments 66 Poorly Controlled 66 Genetic Mutation 66 Chronic Liver Disease 66 Cell Transplant 66 Allergic Reactions 66 gastrointestinal stromal tumors GIST 66 Liver Toxicity 66 Clinical Outcomes 66 Vaccine Adjuvant 66 Tipranavir 66 Male Infertility 66 Systemic Delivery 66 Renal Failure 66 Darunavir 66 Prostate Biopsy 66 Liver Tumors 66 BAL# [002] 66 Cypher Sirolimus 66 Prevent Stroke 66 Cancer Immunotherapy 66 Myoblast 66 Insulin Sensitivity 66 Acute Liver Failure 66 Pegylated Liposomal Doxorubicin 66 Treprostinil 66 Cetrorelix 66 Cancer Therapies 66 brand ciclesonide HFA 66 sorafenib tablets 66 Serdolect ® 66 Neuroendocrine Tumors 66 Breast Cancer Patients 66 Targeted Therapies 66 Gout Patients 66 Non Inferiority 66 Treatment Naive 66 Spinal Manipulation 66 Reduce Mortality 66 Genetic Marker 66 Multicenter Study 66 Dose Ranging 66 Insulin Therapy 66 Systemic Sclerosis 66 Migraine Treatment 66 YONDELIS 66 Lacosamide 66 Impaired Glucose Tolerance 66 Cardiac Resynchronization 66 Percutaneous Tibial Nerve Stimulation 66 BUPHENYL R 66 Neuropathic Pain 66 Clinically Tested 66 Galantamine 66 Breast Tumors 66 Prognostic Value 66 ThermoDox R 66 Announces Poster Presentations 66 Epoetin 66 Infliximab

Back to home page